Pharma Industry
Industry: Email Alert RSS FeedFDA panel gives partial backing for Cephalon's Provigil, but not sleepiness.
Pharma Marketletter, October, 2003
The US Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee has backed approval of two new indications for Cephalon's narcolepsy drug Provigil (modafinil), but split down the middle, four-four, on whether the firm should be able to broadly claim the stimulant improves wakefulness in patients with excessive sleepiness associated with disorders of sleep and wakefulness.
Committee members said West Chester, Pennsylvania-based Cephalon had not proven that Provigil was equally effective in every sleep disorder. Panel chairman Claudia Kawas said she worried that, if Cephalon was awarded broad labeling, patients would be given a pill without getting a full work-up for sleep disorders. "We're talking about treating a symptom without...
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- La anemia falciforme - causas y tratamiento


